We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+2.1%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
AUM
$125M
AUM Growth
-$131M
Cap. Flow
-$122M
Cap. Flow %
-97.07%
Top 10 Hldgs %
39.36%
Holding
112
New
21
Increased
21
Reduced
8
Closed
32

Sector Composition

Rank Sector Weight
1 Healthcare 26.12%
2 Consumer Discretionary 12.52%
3 Technology 11.2%
4 Communication Services 9.58%
5 Financials 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
101
DELISTED
Alexion Pharmaceuticals
ALXN
-4,500
Closed -$551K
GSUM
102
DELISTED
Gridsum Holding Inc.
GSUM
-87,219
Closed -$1.47M
SINA
103
CALL
DELISTED
Sina Corp
SINA
-10,000
Closed -$778K
VRTU
104
DELISTED
Virtusa Corporation
VRTU
-22,500
Closed -$555K
WUBA
105
DELISTED
58.com Inc
WUBA
-5,000
Closed -$238K
GNC
106
DELISTED
GNC Holdings, Inc.
GNC
-45,000
Closed -$919K
SHOR
107
DELISTED
ShoreTel, Inc.
SHOR
-90,000
Closed -$720K
STV
108
DELISTED
China Digital Tv Hldgs Co Ltd
STV
-162,251
Closed -$191K
MEET
109
DELISTED
The Meet Group, Inc. Common Stock
MEET
-292,300
Closed -$1.81M
PSG
110
DELISTED
Performance Sports Group Ltd.
PSG
-360,000
Closed -$1.46M
OMED
111
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
-79,650
Closed -$910K
CHA
112
DELISTED
China Telecom Corporation, LTD
CHA
-7,000
Closed -$357K

Similar funds

Granite Point Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Granite Point Capital Management held 112 positions worth $125M, down 51% from $256M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Granite Point Capital Management withdrew a net $122M in Q4 2016, closing 32 positions and reducing 8 holdings. Its most notable exit was Apple, an estimated $4.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Granite Point Capital Management opened a new position in Alnylam Pharmaceuticals worth $4.12M.

  • Granite Point Capital Management's largest Q4 2016 buy was Alnylam Pharmaceuticals: 110,000 shares worth $4.12M.
  • Granite Point Capital Management added most to Axogen in Q4 2016, an estimated $2.46M increase.
  • Granite Point Capital Management's biggest Q4 2016 reduction was Sarepta Therapeutics, cutting an estimated $4.02M.
  • Granite Point Capital Management fully exited Apple in Q4 2016, selling an estimated $4.91M.
  • Granite Point Capital Management's ten largest holdings make up 39% of its $125M portfolio in Q4 2016.
  • Granite Point Capital Management opened 21 new positions and closed 32 in Q4 2016.
  • Granite Point Capital Management's portfolio value fell 51% quarter-over-quarter to $125M.

Based on Granite Point Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.